{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:16:15Z","timestamp":1792444575761,"version":"4.5.0"},"reference-count":110,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mast cells have been recognized for well over 100 years. With time, human mast cells have been documented to originate from CD34+ cells, and have been implicated in host responses in both innate and acquired immunity. In clinical immunology, they are recognized for their central role in IgE-mediated degranulation and allergic inflammation by virtue of their expression of the high-affinity receptor for IgE and release of potent proinflammatory mediators. In hematology, the clinical disease of mastocytosis is characterized by a pathologic increase of mast cells in tissues, often associated with mutations in KIT, the receptor for stem cell factor. More recently, and with increased understanding of how human mast cells are activated through receptors including the high-affinity receptor for IgE and KIT, specific tyrosine kinase inhibitors have been identified with the potential to interrupt signaling pathways and thus limit the proliferation of mast cells as well as their activation through immunoglobulin receptors.<\/jats:p>","DOI":"10.1182\/blood-2007-11-078097","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T20:23:11Z","timestamp":1218054191000},"page":"946-956","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":453,"title":["Mast cells and mastocytosis"],"prefix":"10.1182","volume":"112","author":[{"given":"Dean D.","family":"Metcalfe","sequence":"first","affiliation":[{"name":"Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111721505801800_B1","doi-asserted-by":"crossref","first-page":"36189","DOI":"10.1074\/jbc.M005830200","article-title":"Occurrence of heparin in the invertebrate styela plicata (tunicata) is restricted to cell layers facing the outside environment.","volume":"275","author":"Cavalcante","year":"2000","journal-title":"J Biol Chem"},{"key":"2019111721505801800_B2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.1780310820","article-title":"Demonstration and characterization of a transient arthritis in rats following sensitization of synovial mast cells with antigen-specific IgE and parenteral challenge with specific antigen.","volume":"31","author":"Malone","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2019111721505801800_B3","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.0610852103","article-title":"Mast cells contribute to initiation of autoantibody-mediated arthritis via lL-1.","volume":"104","author":"Nigrovic","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1165\/rcmb.2006-0197OC","article-title":"Silica directed mast cell activation is enhanced by scavenger receptors.","volume":"36","author":"Brown","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2019111721505801800_B5","article-title":"Beitrage zur theorie und praxis der histologischen f\u00e4rbung [thesis].","author":"Ehrlich","year":"1878"},{"key":"2019111721505801800_B6","first-page":"367","article-title":"Die spezifische f\u00e4rbung der mastzellenk\u00f6rnung.","volume":"19","author":"Unna","year":"1894","journal-title":"Monatsh Prakt Dermatol"},{"key":"2019111721505801800_B7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/aja.1000490206","article-title":"Peritoneal reactions in the white rat, with especial reference to the mast cells.","volume":"49","author":"Webb","year":"1931","journal-title":"Am J Anat"},{"key":"2019111721505801800_B8","first-page":"30","article-title":"The site of formation of heparin.","volume-title":"Heparin: Its Chemistry, Physiology, and Application in Medicine","author":"Jorpes","year":"1939"},{"key":"2019111721505801800_B9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.118.3064.332","article-title":"Histamine in tissue mast cells.","volume":"118","author":"Riley","year":"1953","journal-title":"Science"},{"key":"2019111721505801800_B10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0014-4827(59)90316-7","article-title":"Isolation of biologically intact mast cells.","volume":"18","author":"Diamant","year":"1959","journal-title":"Exp Cell Res"},{"key":"2019111721505801800_B11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.113.3.541","article-title":"Anaphylaxis in chopped guinea pig lung. II. Enhancement of the anaphylactic release of histamine and slow reacting substance by certain dibasic aliphatic acids and inhibition by monobasic fatty acids.","volume":"113","author":"Austin","year":"1961","journal-title":"J Exp Med"},{"key":"2019111721505801800_B12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4049\/jimmunol.93.4.525","article-title":"In vitro passive sensitization of chopped guinea pig lung by guinea pig 7s antibodies.","volume":"93","author":"Baker","year":"1964","journal-title":"J Immunol"},{"key":"2019111721505801800_B13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.127.4.767","article-title":"Antigen-induced release of slow reacting substance of anaphylaxis (SRS-A rat) in rats prepared with homologous antibody.","volume":"127","author":"Orange","year":"1968","journal-title":"J Exp Med"},{"key":"2019111721505801800_B14","first-page":"323","article-title":"Rare forms of urticaria.","volume":"2","author":"Nettleship","year":"1869","journal-title":"Br Med J"},{"key":"2019111721505801800_B15","first-page":"161","article-title":"An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, \u201curticaria pigmentosa?\u201d","volume":"11","author":"Sangster","year":"1878","journal-title":"Trans Clin Soc London"},{"key":"2019111721505801800_B16","first-page":"426","article-title":"Urticaria pigmentosa: a report of a case with autopsy.","volume":"48","author":"Ellis","year":"1949","journal-title":"AMA Arch Pathol"},{"key":"2019111721505801800_B17","first-page":"111","article-title":"Les mastocytoses.","volume":"72","author":"Degos","year":"1956","journal-title":"Bull Soc Med H\u00f4p (Paris)"},{"key":"2019111721505801800_B18","first-page":"291","article-title":"Mastocytosis.","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics in Tumours of Haematopoietic and Lymphoid Tissues","author":"Valent","year":"2001"},{"key":"2019111721505801800_B19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statement on diagnostics, treatment recommendations and response criteria.","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"2019111721505801800_B20","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy.","author":"Brown","journal-title":"Clin Exp Allergy"},{"key":"2019111721505801800_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01966825","article-title":"Typical and atypical mast cells of the rat gastrointestinal system: distribution and correlation with tissue histamine.","volume":"14","author":"Saavedra-Delgado","year":"1984","journal-title":"Agents Action"},{"key":"2019111721505801800_B22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaci.2006.09.003","article-title":"Human mast cells are capable of serotonin synthesis and release.","volume":"11","author":"Kushnir-Sukhov","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B23","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI109613","article-title":"Isolation and characterization of heparin from human lung.","volume":"64","author":"Metcalfe","year":"1979","journal-title":"J Clin Invest"},{"key":"2019111721505801800_B24","first-page":"23","article-title":"Human gastric mucosal mast cells are chondroitin sulphate E-containing mast cell.","volume":"62","author":"Gilead","year":"1987","journal-title":"Immunology"},{"key":"2019111721505801800_B25","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1016\/S0021-9258(19)70198-7","article-title":"Polydispersity of rat mast cell heparin: implications for proteoglycan assembly.","volume":"255","author":"Metcalfe","year":"1980","journal-title":"J Biol Chem"},{"key":"2019111721505801800_B26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.82.5.1321","article-title":"Molecular cloning and sequence analysis of a chondroitin sulfate proteoglycan cDNA.","volume":"82","author":"Bourdon","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B27","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1073\/pnas.86.10.3763","article-title":"Molecular cloning of a cDNA that encodes the peptide core of a mouse mast cell secretory granule proteogylcan and comparison with the analogous rat and human cDNA.","volume":"86","author":"Avraham","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj2720051","article-title":"Oxidative degradation of rat mast cell heparin proteogylcan.","volume":"272","author":"Metcalfe","year":"1990","journal-title":"Biochem J"},{"key":"2019111721505801800_B29","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/S0021-9258(17)38401-6","article-title":"Regulation of tryptase from human lung mast cells by heparin: stabilization of the active tetramer.","volume":"261","author":"Schwartz","year":"1986","journal-title":"J Biol Chem"},{"key":"2019111721505801800_B30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.2007.00509.x","article-title":"Mast cell tryptases and chymases inflammation and host defense.","volume":"217","author":"Caughey","year":"2007","journal-title":"Immunol Rev"},{"key":"2019111721505801800_B31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2222.1990.tb02775.x","article-title":"Mast cells in cutaneous mastocystosis: accumulation of the MC TC type.","volume":"20","author":"Iran","year":"1990","journal-title":"Clin Exp Allergy"},{"key":"2019111721505801800_B32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.104.2.335","article-title":"The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung.","volume":"104","author":"Ishizaka","year":"1970","journal-title":"J Immunol"},{"key":"2019111721505801800_B33","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.76.9.4275","article-title":"Leukotriene C: a slow-reacting substance from murine mastocytoma cells.","volume":"76","author":"Murphy","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.193.1.123","article-title":"T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C4 synthase expression by interleukin 4.","volume":"193","author":"Hsieh","year":"2001","journal-title":"J Exp Med"},{"key":"2019111721505801800_B35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1523-1747.ep12531738","article-title":"Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin.","volume":"80","author":"Soter","year":"1983","journal-title":"J Invest Dermatol"},{"key":"2019111721505801800_B36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1126\/science.7063880","article-title":"Bronchoconstrictor effects of leukotriene C in humans.","volume":"216","author":"Weiss","year":"1982","journal-title":"Science"},{"key":"2019111721505801800_B37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/339064a0","article-title":"Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.","volume":"339","author":"Plaut","year":"1989","journal-title":"Nature"},{"key":"2019111721505801800_B38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/346274a0","article-title":"Mast cells as a source of both preformed and immunologically inducible TNF-alpha\/cachectin.","volume":"346","author":"Gordon","year":"1990","journal-title":"Nature"},{"key":"2019111721505801800_B39","first-page":"147","article-title":"Endothelins belong to the assortment of mast cell derived and mast cell associated cytokines.","volume":"4","author":"Ehrenreich","year":"1992","journal-title":"New Biologist"},{"key":"2019111721505801800_B40","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.159.6.2904","article-title":"Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16.","volume":"159","author":"Rumsaeng","year":"1997","journal-title":"J Immunol"},{"key":"2019111721505801800_B41","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/eji.1830270925","article-title":"Human mast cells express functional TRKA and are a source of nerve growth factor.","volume":"27","author":"Nilsson","year":"1997","journal-title":"Eur J Immunol"},{"key":"2019111721505801800_B42","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.166.7.4705","article-title":"A comparison of mediators released or generated by IFN-\u03b3 treated human mast cells following aggregation of Fc\u03b3RI or Fc\u03b3RI aggregation.","volume":"166","author":"Okayama","year":"2001","journal-title":"J Immunol"},{"key":"2019111721505801800_B43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1165\/ajrcmb.25.6.4541","article-title":"Secretion of interleukin-1 receptor antagonist from human mast cells following IgE mediated activation and following segmental antigen challenge.","volume":"25","author":"Hagaman","year":"2001","journal-title":"Am J Resp Cell Mol Biol"},{"key":"2019111721505801800_B44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0091-6749(99)70292-7","article-title":"Frequency and characterization of antigen-specific IL-4 and IL-13 producing basophils and T cells in peripheral blood of normals and asthmatics.","volume":"104","author":"Devouassoux","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","article-title":"Activation of mast cells by double-stranded RNA: evidence for activation through toll-like receptor-3 (TLR-3).","volume":"114","author":"Kulka","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/268442a0","article-title":"Development of mast cells from grafted bone marrow cells in irradiated mice.","volume":"268","author":"Kitamura","year":"1977","journal-title":"Nature"},{"key":"2019111721505801800_B47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/291332a0","article-title":"Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells.","volume":"291","author":"Nabel","year":"1981","journal-title":"Nature"},{"key":"2019111721505801800_B48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4049\/jimmunol.131.1.282","article-title":"Biologic properties of homogenous interleukin 3.","volume":"131","author":"Ihle","year":"1983","journal-title":"J Immunol"},{"key":"2019111721505801800_B49","first-page":"595","article-title":"Interleukin 3-dependent growth of basophil-like cells and mast-like cells from human bone marrow.","volume":"83","author":"Kirshenbaum","year":"1989","journal-title":"J Immunol"},{"key":"2019111721505801800_B50","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1182\/blood.V73.7.1763.1763","article-title":"Interleukin-3 is a differentiation factor for human basophils.","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"2019111721505801800_B51","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J Immunol"},{"key":"2019111721505801800_B52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0092-8674(90)90300-4","article-title":"Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium.","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"key":"2019111721505801800_B53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90303-V","article-title":"The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus.","volume":"63","author":"Huang","year":"1990","journal-title":"Cell"},{"key":"2019111721505801800_B54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(90)90304-W","article-title":"Molecular cloning of mast cell growth factor: hematopoietin that is active in both membrane bound and soluble forms.","volume":"63","author":"Anderson","year":"1990","journal-title":"Cell"},{"key":"2019111721505801800_B55","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"The effect of IL-3 and stem cell factor on the appearance of mast cells and basophils from CD34+ pluripotent progenitor cells.","volume":"148","author":"Kirshenbaum","year":"1992","journal-title":"J Immunol"},{"key":"2019111721505801800_B56","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant stem cell factor\/kit-ligand in long-term culture.","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"2019111721505801800_B57","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a bipotential progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13).","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"2019111721505801800_B58","first-page":"245","article-title":"Inhibition of human mast cell growth and differentiation by interferon gamma-1\u03b2.","volume":"26","author":"Kirshenbaum","year":"1998","journal-title":"Exp Hematol"},{"key":"2019111721505801800_B59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood-2004-07-2838","article-title":"High resolution tracking of cell division demonstrates differential effects of TH-1 and TH-2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and Kit expression.","volume":"105","author":"Kulka","year":"2005","journal-title":"Blood"},{"key":"2019111721505801800_B60","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1182\/blood-2004-03-1166","article-title":"Lysophosphatidic acid accelerates the development of human mast cells.","volume":"104","author":"Bagga","year":"2004","journal-title":"Blood"},{"key":"2019111721505801800_B61","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.177.5.2755","article-title":"Cutting edge: interleukin 4-dependent mast cell proliferation requires autocrine\/intracrine cysteinyl leukotriene-induced signaling.","volume":"177","author":"Jiang","year":"2006","journal-title":"J Immunol"},{"key":"2019111721505801800_B62","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.exphem.2004.12.005","article-title":"Thrombopoietin alone or in the presence of stem cell factor supports the growth of KIT (CD117)low\/MPL (CD110)+ human mast cells from hematopoietic progenitor cells.","volume":"33","author":"Kirshenbaum","year":"2005","journal-title":"Exp Hematol"},{"key":"2019111721505801800_B63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/320415a0","article-title":"A new acute transforming feline retrovirus and relationship of its oncogene v-kit with protein kinase gene family.","volume":"320","author":"Besmer","year":"1986","journal-title":"Nature"},{"key":"2019111721505801800_B64","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics.","volume":"114","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B65","first-page":"965","article-title":"The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.","author":"Galli","year":"1993","journal-title":"Am J Pathol"},{"key":"2019111721505801800_B66","first-page":"160","article-title":"Studien \u00fcber die VerberempFindlichkeit.","volume":"86","author":"Prausnitz","year":"1921","journal-title":"Z Bakt"},{"key":"2019111721505801800_B67","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4049\/jimmunol.97.6.840","article-title":"Physiochemical properties of reagenic antibody: V correlation of reaginic activity with \u03b3\u03f5 globulin antibody.","volume":"97","author":"Ishizaka","year":"1966","journal-title":"J Immunol"},{"key":"2019111721505801800_B68","first-page":"381","article-title":"Immunological studies of an atypical myeloma immunoglobulin.","volume":"13","author":"Johansson","year":"1967","journal-title":"Immunology"},{"key":"2019111721505801800_B69","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI109103","article-title":"IgE receptors on human basophils. Relationship to serum IgE concentration.","volume":"62","author":"Malveaux","year":"1978","journal-title":"J Clin Invest"},{"key":"2019111721505801800_B70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/337187a0","article-title":"Complete structure and expression in transfected cells of high affinity IgE receptor.","volume":"337","author":"Blank","year":"1989","journal-title":"Nature"},{"key":"2019111721505801800_B71","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.2523561","article-title":"Expression of high-affinity binding of human immunoglobulin E by transfected cells.","volume":"244","author":"Miller","year":"1989","journal-title":"Science"},{"key":"2019111721505801800_B72","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1073\/pnas.87.14.5327","article-title":"Tyrosine phosphorylation coupled to IgE receptor-mediated signal transduction and histamine release.","volume":"87","author":"Benhamou","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B73","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/353855a0","article-title":"Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement.","volume":"353","author":"Paolini","year":"1991","journal-title":"Nature"},{"key":"2019111721505801800_B74","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ni817","article-title":"Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation.","volume":"3","author":"Parravicin","year":"2002","journal-title":"Nat Immunol"},{"key":"2019111721505801800_B75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/blood-2003-08-2769","article-title":"NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc\u03b5R1 aggregation.","volume":"104","author":"Tkaczyk","year":"2004","journal-title":"Blood"},{"key":"2019111721505801800_B76","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.175.7.4167","article-title":"Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.","volume":"175","author":"Kawakami","year":"2005","journal-title":"J Immunol"},{"key":"2019111721505801800_B77","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.4049\/jimmunol.164.8.4332","article-title":"Expression of a functional high affinity IgG receptor (Fc\u03b3RI) on human mast cells: up-regulation by IFN-\u03b3.","volume":"164","author":"Okayama","year":"2000","journal-title":"J Immunol"},{"key":"2019111721505801800_B78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/381075a0","article-title":"Critical protective role of mast cells in a model of acute septic peritonitis.","volume":"381","author":"Echtenacher","year":"1996","journal-title":"Nature"},{"key":"2019111721505801800_B79","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1084\/jem.188.12.2343","article-title":"The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells.","volume":"188","author":"Maurer","year":"1998","journal-title":"J Exp Med"},{"key":"2019111721505801800_B80","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status.","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"2019111721505801800_B81","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM199305063281803","article-title":"Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.","volume":"328","author":"Longley","year":"1993","journal-title":"N Engl J Med"},{"key":"2019111721505801800_B82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1067\/mai.2002.120524","article-title":"Levels of mast cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast cell numbers and mast cell tryptase.","volume":"109","author":"Brockow","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B83","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in the peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111721505801800_B84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"2019111721505801800_B85","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"2019111721505801800_B86","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: Pathology, genetics, and current opinions for therapy.","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"2019111721505801800_B87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaci.2004.04.046","article-title":"The biology of Kit in disease and the application of pharmacogenetics.","volume":"114","author":"Akin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B88","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1182\/blood.V98.3.880","article-title":"Association of the Q576R polymorphism in the interleukin-4 receptor \u03b1 chain with indolent mastocytosis limited to the skin.","volume":"98","author":"Daley","year":"2001","journal-title":"Blood"},{"key":"2019111721505801800_B89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.11836","article-title":"Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and PRKG2-PDGFRB fusion.","volume":"93","author":"Lahortiga","year":"2008","journal-title":"Haematologica"},{"key":"2019111721505801800_B90","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/ PDGFRA-associated chronic eosinophilic leukemia are distinct entities.","volume":"120","author":"Maric","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B91","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am J Med"},{"key":"2019111721505801800_B92","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent system mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"2019111721505801800_B93","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic nastocytosis (SM) in routinely processed bone marrow biopsy specimens.","volume":"28","author":"Soltar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2019111721505801800_B94","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of the literature.","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"2019111721505801800_B95","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0091-6749(98)70144-7","article-title":"Cytogenetic abnormalities and their lack of relationship to the Asp816Val c-kit mutation in the pathogenesis of mastocytosis.","volume":"102","author":"Worobec","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2019111721505801800_B96","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders.","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"2019111721505801800_B97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.0960-135X.2004.01369.x","article-title":"On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment concepts.","volume":"34","author":"Valent","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"2019111721505801800_B98","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa 2b in a patient with systemic mastocytosis.","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N Engl J Med"},{"key":"2019111721505801800_B99","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"2019111721505801800_B100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine.","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"key":"2019111721505801800_B101","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis.","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"2019111721505801800_B102","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit.","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"2019111721505801800_B103","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"2019111721505801800_B104","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(03)14115-3","article-title":"Imatinib for systemic mast-cell disease.","volume":"362","author":"Pardanani","year":"2003","journal-title":"Lancet"},{"key":"2019111721505801800_B105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.leukres.2003.09.001","article-title":"Inefficacy of imatinib-mesylate in sporadic, aggressive systemic mastocytosis.","volume":"28","author":"Musto","year":"2004","journal-title":"Leuk Res"},{"key":"2019111721505801800_B106","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"2019111721505801800_B107","first-page":"94","article-title":"Splenectomy in the management of systemic mast cell disease 205.","volume":"107","author":"Friedman","year":"1990","journal-title":"Surgery"},{"key":"2019111721505801800_B108","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1096-8652(199801)57:1<24::AID-AJH4>3.0.CO;2-3","article-title":"Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases.","volume":"57","author":"Przepiorka","year":"1998","journal-title":"Am J Hematol"},{"key":"2019111721505801800_B109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bmt.1705245","article-title":"A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis.","volume":"37","author":"Nakamura","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2019111721505801800_B110","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood-2005-04-1568","article-title":"Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.","volume":"106","author":"Gotlib","year":"2005","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/4\/946\/1457011\/zh801608000946.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/4\/946\/1457011\/zh801608000946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:31:43Z","timestamp":1684503103000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/4\/946\/25264\/Mast-cells-and-mastocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-11-078097","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}